NCT01107626
Clinical Trial Information
Trial Number: NCT01107626 (ClinicalTrials.gov)
Disease Type:
- Lung, Mediastinal and Pleural Neoplasm - Non-Small Cell Lung Cancer
Trial Title:
Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
Study ID:
E5508
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01107626-D2 | There are two different submissions for PMID 31361535 from trial E5508. This dataset, NCT01107626-D2, contains toxicity data. Dataset NCT01107626-D1 contains baseline, treatment, and efficacy data. |
| NCT01107626-D1 | There are two different submissions for PMID 31361535 from trial E5508. This dataset, NCT01107626-D1, contains baseline, treatment, and efficacy data. Dataset NCT01107626-D2 contains toxicity data. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®